Sharemaestro Newsreel

Globus Medical (NYSE:GMED) Releases Earnings Results, Beats Expectations By $0.24 EPS

Enovis (NYSE:ENOV) Posts Quarterly Earnings Results, Beats Estimates By $0.05 EPS

Enovis (ENOV) reported Q2 earnings of $0.9 per share, exceeding the Zacks Consensus Estimate of $0.83, and revenues of $582.78 million, also surpassing estimates. The company has consistently beaten EPS estimates over the last four quarters and revenue estimates three out of the last …

Integer Holdings Corp (ITGR) News, Articles, Events & Latest Updates

Integer Holdings Corp (ITGR) has been in the news due to its Q2 earnings exceeding estimates, a proposed acquisition by KKR for $5.7 billion, and several shareholder alerts regarding the fairness of the deal. Multiple law firms are investigating whether the proposed sale price …

VAREX IMAGING Q3 2026 Earnings Preview: Recent $VREX Insider Trading, Hedge Fund Activity, and More

TACTILE SYSTEMS TECHNOLOGY Q2 2026 Earnings Preview: Recent $TCMD Insider Trading, Hedge Fund Activity, and More

Irhythm Technologies Boosts Outlook, Expands Cardiac Monitoring Platform

iRhythm Technologies (IRTC) recently settled a patent dispute for $50 million and announced strong Q2 2026 results, including a 20.1% revenue increase and improved margins. The company also secured FDA clearance for a new algorithm and plans to acquire Vital Connect for $287.5 million …

Avita Medical (NASDAQ:RCEL) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Avita Medical (NASDAQ:RCEL) announced its quarterly earnings, beating analyst estimates with an adjusted loss of $0.25 per share on revenue of $21.7 million. The company's revenue increased 18% year-over-year, driven by strong RECELL sales, and management raised its 2026 revenue guidance. Avita Medical expects …

Inogen (NASDAQ:INGN) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Inogen (NASDAQ:INGN) reported quarterly earnings, beating expectations with a loss of $0.14 per share against a projected $0.15 loss. While revenue slightly missed estimates at $95.08 million, the company showed improved profitability with a 15% rise in adjusted EBITDA and strong international sales growth. …

Quantinno Capital Management LP Reduces Holdings in Integra LifeSciences Holdings Corporation $IART

Quantinno Capital Management LP significantly reduced its stake in Integra LifeSciences Holdings Corporation (NASDAQ:IART) by 45.4% in the first quarter of 2026, selling 382,663 shares. Despite this reduction, other institutional investors like Paradigm Capital, Sei Investments, and Walleye Capital increased their holdings, maintaining high …

PROCEPT BioRobotics Corp. Revenue Breakdown – BMV:PRCT

PROCEPT BioRobotics Corp. (BMV:PRCT) generated 5.55 billion MXN in revenue last year. The "Hand Pieces and Other Consumables" segment was the top performer, contributing 3.27 billion MXN, an increase from 2.53 billion MXN the previous year. The United States was the primary revenue source, …

Rapid Micro Biosystems, Inc. (RPID) Leadership & Management Team Analysis

This article provides an in-depth analysis of Rapid Micro Biosystems, Inc. (RPID)'s leadership, management team, and recent company updates. It highlights CEO Rob Spignesi's compensation and ownership, along with details on insider transactions, board changes, and financial risks. The company faces challenges such as …

Earnings Preview: LENSAR to Report Financial Results Pre-market on August 13

This article provides an earnings preview for LENSAR (NASDAQ: LNSR), which is scheduled to release its Q2 2024 financial results before the market opens on August 13, 2024. The company has a history of beating EPS estimates but missing revenue forecasts. Investors will be …

AHCO Investors Have Opportunity to Join AdaptHealth Corp. Fraud Investigation with SBS Law

Schall, Brown & Schwartz LLP (SBS) is investigating potential securities law violations by AdaptHealth Corp. (NASDAQ: AHCO) on behalf of its investors. This investigation follows AdaptHealth's Q2 2026 financial results, where the company missed earnings estimates and significantly cut its full-year guidance, leading to …

Apyx Medical Corporation (NASDAQ:APYX) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Apyx Medical Corporation (NASDAQ:APYX) has received a "Moderate Buy" consensus recommendation from seven brokerages, with an average 12-month price target of $6.60, significantly higher than its current $4.05 price. The company recently surpassed earnings estimates, reporting a smaller adjusted loss and higher revenue than …

Medtronic PLC (MDT) Stock Analysis & Forecast

This article provides an analysis and forecast for Medtronic PLC (MDT) stock. It includes recent stock performance data, key financial metrics, and mentions two in-depth analyses published by TradingKey. These analyses cover broader market trends and Medtronic's strategy for capitalizing on the aging global …

Neogen Corporation (NEOG) Stock Forecasts

Argus has raised its target price for Neogen Corporation (NEOG) to $12.00, citing the company's focus on food and animal safety products. Neogen, based in Lansing, Michigan, develops, manufactures, and markets these products. The report provides a summary of the company and suggests upgrading …

NovoCure (NASDAQ:NVCR) Rating Increased to Buy at Wall Street Zen

Wall Street Zen has upgraded NovoCure (NASDAQ:NVCR) to a "Buy" rating, despite a broader analyst consensus of "Hold" with an average price target of $21.20. The upgrade follows NovoCure's strong quarterly results, where adjusted EPS loss of $0.13 significantly beat the anticipated $0.33 loss, …

Artivion (AORT) Stock Can Revenue Growth Outrun Fresh Losses?

Artivion (AORT) saw its stock edge up slightly despite a mixed Q2 2026 earnings report, which showed strong revenue growth but a swing back to a net loss. The company's aortic franchise, particularly with AMDS approval and growth in On X valves, fuels the …

Lifeward Ltd (LFWD) Earnings Forecast: Future EPS & Revenue Growth Estimates

Lifeward Ltd (LFWD) has an earnings forecast score of 8.00, ranking 65th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $4.50, with a high of $10.00 and a low of $1.00. Based on ratings from two analysts, …

908 Devices | 4: Statement of changes in beneficial ownership of securities-Director Brown Christopher D.

This document is a statement of changes in beneficial ownership of securities for Director Christopher D. Brown of 908 Devices. It reports transactions related to his holdings in the company.

CONMED (CNMD) Lifts Sales Outlook, Is The Stock 24% Overvalued?

LivaNova (LIVN) Rebounds On Earnings As The Bull Case Points To More Upside

Conmed Corp (CNMD) Stock News Today

This page provides an overview of Conmed Corp (CNMD) stock information, including its current market price, market capitalization, and P/E ratio. It also indicates that more news and analysis regarding the company's stock, earnings, and analyst ratings will be available soon. The platform, TradingKey, …

Elutia Inc (ELUT) Earnings Forecast: Future EPS & Revenue Growth Estimates

Is Glaukos (GKOS) Undervalued Following Record Sales And Higher 2026 Guidance?

Competition Is Heating Up, but Here's Why Intuitive Surgical Might Still Be the Smartest Bet in MedTech

Key Points Intuitive Surgical makes the da Vinci surgical robot, with 11,710 systems in use globally. Medical device competitors Medtronic and Johnson & Johnson are bringing out their own surgical robots. Intuitive Surgical's largest revenue source isn't the sale of new da Vinci systems.10 …

PROCEPT BioRobotics (PRCT) Stock Sees Fair Value Falls As Analysts Cut Growth Views

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Price targets for PROCEPT BioRobotics have been reset closer to its revised fair value, with many now clustered in the low to mid …

Abbott Laboratories (ABT) Could Be 10% Undervalued On Its $1.35b Buyback Update

Abbott Laboratories (ABT) has completed a $1.35 billion share buyback, repurchasing over 14 million shares. Despite recent short-term gains, the company's shares are considered 9.5% undervalued, with a fair value estimated at $119.13 compared to its current price of $107.81. Growth drivers include expanding …

AxoGen Inc (AXGN) Stock News Today

This article provides an overview of AxoGen Inc (AXGN) stock, including its current price, market capitalization, and a note that more

ESTABLISHMENT LABS HOLDINGS INC. 2026: Revenue $67.54M, EPS ($0.39) — 10-Q Summary

ESTABLISHMENT LABS HOLDINGS INC. reported strong financial results for 2026, with revenue increasing by 31.7% to $67.54M and net loss narrowing. The growth was primarily driven by expansion in the U.S. market and higher selling prices, with Motiva Implants gaining significant traction after FDA …

Did STERIS’ (STE) Record Chemistries Bet and Dividend Hike Just Recast Its Earnings Narrative?

STERIS plc (STE) recently reported strong Q1 fiscal 2027 results, including increased sales and earnings, a reaffirmed full-year outlook, and its 21st consecutive annual dividend increase. The company also announced a significant US$600 million investment in a new chemistries Center of Excellence in North …

Earnings Scorecard: 95% of healthcare firms deliver EPS wins this week

Major healthcare heavyweights, including Pfizer (PFE [https://seekingalpha.com/symbol/PFE]), Merck (MRK [https://seekingalpha.com/symbol/MRK]), and Eli Lilly (LLY [https://seekingalpha.com/symbol/LLY]), reported their quarterly earnings this week, pushing the healthcare sector into positive territory after five consecutive sessions of losses. The State Street Health Care Select Sector SPDR ETF [https://seekingalpha.com/symbol/XLV] …

Pathfinder Asset Management discloses 7.4% Modular Medical (MODD) holding in 13G

Pathfinder Asset Management Limited has disclosed a 7.4% beneficial ownership stake in Modular Medical, Inc. (MODD) as of June 30, 2026. The Canadian firm reported holding 399,775 shares with sole voting and dispositive power, as detailed in its SCHEDULE 13G filing. This filing indicates …

Evercore Maintains Enovis Corp(ENOV.US) With Buy Rating, Maintains Target Price $32

Evercore has reiterated its Buy rating on Enovis Corp (ENOV.US) and maintained its target price at $32. This indicates a continued positive outlook from the firm regarding the company's stock performance.

Earnings Release: Here's Why Analysts Cut Their Pacific Biosciences of California, Inc. (NASDAQ:PACB) Price Target To US$2.29

Analysts have lowered their price target for Pacific Biosciences of California (NASDAQ:PACB) to US$2.29 after the company's recent earnings report, which saw revenue fall short of estimates and increased projected losses per share for 2026. The revised forecasts indicate a slowdown in revenue growth …

12% Undervalued? GE HealthCare Technologies (GEHC) After New Ultrasound Launches

GE HealthCare Technologies (GEHC) is back in focus after launching new ultrasound systems that were